Climb Bio Inc (CLYM) — Cash Flow Reinvestment Rate
Latest as of September 2023:
8.03x
Climb Bio Inc (CLYM) has a Cash Flow Reinvestment Rate of 8.03x as of September 2023, reinvesting $28.04 Million (capex $0.00 plus investments $28.04 Million) from operating cash flow of $3.49 Million. Explore cash efficiency ratio of Climb Bio Inc to assess how effectively this company generates cash.
Reinvestment Rate
8.03x
(Capex + Investments) / Operating CF
Total Reinvested
$28.04 Million
Capex + Investments
Operating Cash Flow
$3.49 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Climb Bio Inc (None–None)
Year-by-year capital reinvestment analysis for Climb Bio Inc. For live market cap and broader valuation context, see market value of Climb Bio Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow